Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Castle Biosciences, Inc. - Common stock
(NQ:
CSTL
)
18.39
-0.80 (-4.17%)
Streaming Delayed Price
Updated: 2:54 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Castle Biosciences, Inc. - Common stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 06, 2023
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.
Via
Benzinga
Apple To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Tuesday
June 06, 2023
B of A Securities boosted the price target for Molson Coors Beverage Company (NYSE: TAP) from $54 to $68. B of A Securities analyst Bryan Spillane upgraded the stock from Underperform to Neutral....
Via
Benzinga
7 Analysts Have This to Say About Castle Biosciences
June 05, 2023
Via
Benzinga
Dow Drops Triple Digits; S&P 500, Nasdaq Extend Highs
June 05, 2023
Via
Talk Markets
Why Shares of Castle Biosciences Slumped This Week
June 02, 2023
Investors were unimpressed by the company's study regarding its IDgenetix test.
Via
The Motley Fool
Looking Into Castle Biosciences's Return On Capital Employed
May 11, 2023
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Castle Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
June 06, 2023
From
The Schall Law Firm
Via
Business Wire
Why Shares of Castle Biosciences Plummeted on Monday
June 05, 2023
Analysts downgraded their price target for the medical diagnostics stock.
Via
The Motley Fool
Dow Drops Over 100 Points; Crude Oil Rises
June 05, 2023
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also...
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Castle Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
June 05, 2023
From
The Schall Law Firm
Via
Business Wire
Analyst Expectations for Castle Biosciences's Future
May 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 05, 2023
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 05, 2023
Monday's session saw 41 companies set new 52-week lows.
Via
Benzinga
Nasdaq Rises 70 Points; ISM Services PMI Drops In May
June 05, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,...
Via
Benzinga
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday
June 05, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Mixed; SAIC Posts Upbeat Results
June 05, 2023
U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.06% to 33,740.98 while the NASDAQ rose 0.08% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Framework Incorporating DecisionDx®-SCC Test Results into Clinical Decision-Making for Patients with High-Risk Cutaneous Squamous Cell Carcinoma Published in Clinical, Cosmetic and Investigational Dermatology
June 05, 2023
From
Castle Biosciences Inc.
Via
Business Wire
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
June 03, 2023
From
Castle Biosciences Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 01, 2023
Gainers Reunion Neuroscience Inc. (NASDAQ: REUN) gained 95% to $1.33 after the company announced a $13.1 million take-private transaction with MPM BioImpact.
Via
Benzinga
IDgenetix® Shown to Significantly Improve Medication Response and Remission Rates in Patients with Major Depressive Disorder
May 31, 2023
From
Castle Biosciences Inc.
Via
Business Wire
Castle Biosciences Celebrates Skin Cancer Awareness Month
May 30, 2023
From
Castle Biosciences Inc.
Via
Business Wire
Castle Biosciences’ Abstracts at Digestive Disease Week (DDW) Annual Meeting Selected as “Posters of Distinction” by the American Gastroenterological Association (AGA) Institute Council
May 26, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
Castle Biosciences Opens New State-of-the-Art Laboratory in Pittsburgh
May 22, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
Castle Biosciences’ TissueCypher® Barrett's Esophagus Test Receives 2023 MedTech Breakthrough Award for Artificial Intelligence Innovation
May 15, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
Castle Biosciences Reports First Quarter 2023 Results
May 03, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
Study Demonstrates Use of DecisionDx®-Melanoma to Guide Treatment Decisions Resulted in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients Without Surveillance Imaging Studies
May 03, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event
April 28, 2023
From
Castle Biosciences, Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.